Johnson Pharmacare reported a standalone net loss of ₹110.31 lakh for the quarter ended June 30, 2026, marking a sharp deterioration from the ₹5.34 lakh loss posted in the corresponding period of FY25. The Ahmedabad-based pharma company recorded zero total income from operations during the quarter, signaling a continued lack of commercial activity.

The Board of Directors approved the unaudited financial results on August 13, 2026, following review by the Audit Committee. The results were subsequently published in regional newspapers as per SEBI Listing Obligations and Disclosure Requirements (LODR) Regulation 47.

Financial Performance

The company’s financial position reflects ongoing operational challenges. While the previous quarter (Q4FY26) saw a massive audited net loss of ₹5,561.06 lakh, the current quarter’s loss was contained to ₹110.31 lakh. However, the absence of any operating revenue highlights the absence of core business generation.

The earnings per share (EPS) stood at ₹(0.02) for the quarter, compared to negligible losses in the prior year. The company’s paid-up equity share capital remained stable at ₹5,500 lakh.

What the Numbers Show

A critical observation from the filing is the complete absence of operating income alongside a widening net loss. With zero revenue generated from operations, the entire loss figure of ₹110.31 lakh stems from non-operating expenses or overheads rather than trading activities. This divergence between zero top-line growth and increasing bottom-line pressure suggests the company is incurring fixed costs without offsetting sales, a pattern that warrants monitoring for potential cash flow constraints in subsequent quarters.

Johnson Pharmacare reported a widened net loss of ₹5,573.39 lakh for the financial year ended March 31, 2026, significantly higher than the loss of ₹58.38 lakh recorded in the previous year. The company’s total income for the year stood at ₹158.10 lakh, while total expenses surged to ₹4,304.49 lakh, driven largely by other expenses amounting to ₹4,276.48 lakh. The basic and diluted earnings per share (EPS) for the year were reported at negative ₹1.01.

The statutory auditor, VRSK & Associates, issued a disclaimer of opinion on the standalone financial statements, stating they may not give a true and fair view due to the non-provision of interest on loans and non-compliance with Ind AS prescribed under Section 133 of the Companies Act, 2013. The auditor noted that the company should have prepared financial statements in compliance with Ind AS, which may significantly affect the reported figures.

Audit Qualifications and Internal Controls

The audit report highlighted significant deficiencies in the company's internal financial controls. Specifically, the company did not maintain accounting software with a feature to record an audit trail for every transaction, including edit logs with dates, nor did it ensure the audit trail could not be disabled. This failure violates the proviso to Rule 3(1) of the Companies (Accounts) Rules, 2014.

Furthermore, the auditor identified key audit matters concerning inter-corporate deposits and the fair valuation of unquoted investments. The company had a borrowed loan balance of ₹2,140.04 lakh as of March 31, 2026. The auditor noted that the terms of these loans, including repayment schedules and interest rates, were not clearly defined, raising significant risks regarding their conversion to equity capital.

Financial Position and Cash Flows

The company’s balance sheet as of March 31, 2026, showed total assets of ₹2,203.11 lakh, a sharp decline from ₹5,792.59 lakh in the previous year. Non-current investments decreased to ₹1,972.50 lakh from ₹4,229.16 lakh, while borrowings spiked to ₹2,140.19 lakh from ₹60.54 lakh. The net worth of the company stood at ₹43.52 lakh, down from ₹5,616.91 lakh in the prior year.

Cash flow analysis revealed a net decrease in cash and cash equivalents of ₹4.59 lakh during the quarter ended March 31, 2026. The company generated ₹5,783.16 lakh from investing activities, primarily due to an increase in investments, but utilized ₹5,745.54 lakh in operating activities. Financing activities saw a net outflow of ₹42.20 lakh, mainly due to the repayment of long-term borrowings.

Regulatory and Governance Issues

The auditor expressed serious doubts about the company’s ability to meet its liabilities as they fall due within one year from the balance sheet date. Additionally, the report noted that the company is required to be registered with the Reserve Bank of India under Section 45-IA of the RBI Act, 1934, as it extends loans and earns income mainly from interest. However, the company does not meet the criteria for a Core Investment Company.

The board approved the audited financial results at a meeting held on May 27, 2026. The filing was submitted to the stock exchanges on June 19, 2026.